AAAAAA
Results: 1-25/38
Authors:
Furlan, M
Lammle, B
Citation: M. Furlan et B. Lammle, Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease, BEST P R C, 14(2), 2001, pp. 437-454
Authors:
Gungor, T
Furlan, M
Lammle, B
Kuhn, F
Seger, RA
Citation: T. Gungor et al., Acquired deficiency of von Willebrand factor-cleaving protease in a patient suffering from acute systemic lupus erythematosus, RHEUMATOLOG, 40(8), 2001, pp. 940-942
Authors:
Alberio, L
Lammle, B
Esmon, CT
Citation: L. Alberio et al., Protein C replacement in severe meningococcemia: Rationale and clinical experience, CLIN INF D, 32(9), 2001, pp. 1338-1346
Authors:
Alberio, L
Lammle, B
Esmon, CT
Citation: L. Alberio et al., Protein C replacement in severe meningococcemia: rationale and clinical experience ( vol 32, pg 1338, 2001), CLIN INF D, 32(12), 2001, pp. 1803-1803
Authors:
Funfsinn, N
Caliezi, C
Biasiutti, FD
Korte, W
Z'Brun, A
Baumgartner, I
Ulrich, M
Cottier, C
Lammle, B
Wuillemin, WA
Citation: N. Funfsinn et al., Rapid D-dimer testing and pre-test clinical probability in the exclusion of deep venous thrombosis in symptomatic outpatients, BL COAG FIB, 12(3), 2001, pp. 165-170
Authors:
Redondo, M
Carroll, VA
Mauron, T
Biasiutti, FD
Binder, BR
Lammle, B
Wuillemin, WA
Citation: M. Redondo et al., Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha 2-antiplasmin complex is an independent predictor of coronary re-events, BL COAG FIB, 12(1), 2001, pp. 17-24
Authors:
Hunt, BJ
Lammle, B
Nevard, CHF
Haycock, GB
Furlan, M
Citation: Bj. Hunt et al., Von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome, THROMB HAEM, 85(6), 2001, pp. 975-978
Authors:
Oldenburg, J
Kriz, K
Wuillemin, WA
Maly, FE
von Felten, A
Siegemund, A
Keeling, DM
Baker, P
Chu, K
Konkle, BA
Lammle, B
Albert, T
Citation: J. Oldenburg et al., Genetic predisposition to bleeding during oral anticoagulant therapy: Evidence for common founder mutations (FIXVal-10 and FIXThr-10) and an independent CpG hotspot mutation (FIXThr-10), THROMB HAEM, 85(3), 2001, pp. 454-457
Authors:
Wuillemin, WA
Biasiutti, FD
Mattle, HP
Lammle, B
Citation: Wa. Wuillemin et al., Frequency of protein Z deficiency in patients with ischaemic stroke, LANCET, 358(9284), 2001, pp. 840-840
Authors:
Redondo, M
Caliezi, C
Biasiutti, FD
Lammle, B
Wuillemin, WA
Citation: M. Redondo et al., Increased fibrin monomer plasma concentration in stable coronary artery disease in patients without oral anticoagulation, ATHEROSCLER, 157(2), 2001, pp. 417-422
Authors:
Kobelt, K
Biasiutti, FD
Mattle, HP
Lammle, B
Wuillemin, WA
Citation: K. Kobelt et al., Protein Z in ischaemic stroke, BR J HAEM, 114(1), 2001, pp. 169-173
Authors:
Barbot, J
Costa, E
Guerra, M
Barreirinho, MS
Isvarlal, P
Robles, R
Gerritsen, HE
Lammle, B
Furlan, M
Citation: J. Barbot et al., Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease, BR J HAEM, 113(3), 2001, pp. 649-651
Authors:
Fontana, S
Gerritsen, HE
Hovinga, JK
Furlan, M
Lammle, B
Citation: S. Fontana et al., Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease, BR J HAEM, 113(1), 2001, pp. 100-102
Authors:
Gerritsen, HE
Robles, R
Lammle, B
Furlan, M
Citation: He. Gerritsen et al., Partial amino acid sequence of purified von Willebrand factor-cleaving protease, BLOOD, 98(6), 2001, pp. 1654-1661
Authors:
Krebs, T
Zimmerli, S
Bodmer, T
Lammle, B
Citation: T. Krebs et al., Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukaemia, J INTERN M, 248(4), 2000, pp. 343-348
Authors:
Furlan, M
Lammle, B
Citation: M. Furlan et B. Lammle, Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura - new insights into underlying biochemical mechanisms, NEPH DIAL T, 15(8), 2000, pp. 1112-1114
Authors:
Furlan, M
Lammle, B
Citation: M. Furlan et B. Lammle, Splenectomy in thrombotic thrombocytopenic purpura, AM J HEMAT, 64(1), 2000, pp. 79-79
Authors:
Mauron, T
Lammle, B
Wuillemin, WA
Citation: T. Mauron et al., High molecular weight kininogen is cleaved by FXIa at three sites: Arg(409)-Arg(410), Lys(502)-Thr(503) and Lys(325)-Lys(326), THROMB HAEM, 83(5), 2000, pp. 709-714
Authors:
Caliezi, C
Reber, G
Lammle, B
de Moerloose, P
Wuillemin, WA
Citation: C. Caliezi et al., Agreement of D-dimer results measured by a rapid ELISA (VIDAS) before and after storage during 24 h or transportation of the original whole blood samples, THROMB HAEM, 83(1), 2000, pp. 177-178
Authors:
Caliezi, C
Waber, M
Pfiffner, D
Saner, H
Lammle, B
Wuillemin, WA
Citation: C. Caliezi et al., Patient self-control of oral anticoagulation with CoaguChek (R), SCHW MED WO, 130(24), 2000, pp. 916-923
Authors:
Redondo, M
Watzke, HH
Stucki, B
Sulzer, I
Biasiutti, FD
Binder, BR
Furlan, M
Lammle, B
Wuillemin, WA
Citation: M. Redondo et al., Coagulation factors II, V, VII, and X, prothrombin gene 20210G -> A transition, and factor V Leiden in coronary artery disease - High factor V clotting activity is an independent risk factor for myocardial infarction, ART THROM V, 19(4), 1999, pp. 1020-1025
Authors:
Stucki, B
Zenhausern, R
Biedermann, B
Baudo, F
Redaelli, R
Lammle, B
Furlan, M
Citation: B. Stucki et al., Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the A alpha-chain (vol 10, pg 93, 1999), BL COAG FIB, 10(4), 1999, pp. NIL_4-NIL_4
Authors:
Stucki, B
Zenhausern, R
Biedermann, B
Baudo, F
Redaelli, R
Lammle, B
Furlan, M
Citation: B. Stucki et al., Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the A alpha-chain, BL COAG FIB, 10(2), 1999, pp. 93-99
Authors:
Lehmann, T
Lammle, B
Citation: T. Lehmann et B. Lammle, IFN alpha treatment in systemic mastocytosis, ANN HEMATOL, 78(10), 1999, pp. 483-484
Authors:
Gerritsen, HE
Turecek, PL
Schwarz, HP
Lammle, B
Furlan, M
Citation: He. Gerritsen et al., Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF - A tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP), THROMB HAEM, 82(5), 1999, pp. 1386-1389